Washington, USA
+919405476170
+919405476170

Sourcing Soralieva 200mg Tablets USA | Trusted Indian Exporter | Ernest Pharmaceutical

Global Exporter & Bulk Supplier: Soralieva 200mg Tablet

🌍 Market Overview

Are you trying to streamline your commercial pharmaceutical supply operations with a certified, reliable international exporter of targeted cancer therapies? Ernest Oncology (the specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd.) is a top-tier global supplier, bulk exporter, and distributor of Soralieva 200mg Tablets.

Utilizing our established international medical logistics framework, we manage high-capacity export programs to distribute Sorafenib 200mg directly to hospital groups, specialized oncology clinics, regional pharmacy networks, and international medical tender operations across the USA, UK, Australia, and South Africa.


🔬 Product Profile: Soralieva 200mg Tablet

Soralieva 200mg contains Sorafenib, a foundational oral multikinase inhibitor. It serves as a vital first-line targeted therapeutic intervention engineered to halt tumor growth and disrupt the blood supply pathways essential for malignancy survival.

  • Active Ingredient: Sorafenib (200mg)

  • Therapeutic Class: Antineoplastic / Multikinase Inhibitor / Raf Kinase & VEGFR Inhibitor

  • Mechanism of Action: Soralieva 200mg exerts a dual-action mechanism of care by targeting both the tumor cell itself and its surrounding vascular networks. It works by inhibiting multiple intracellular and cell-surface kinases. It targets Raf kinases (C-Raf, B-Raf, and mutant B-Raf), effectively blocking the downstream RAF/MEK/ERK signaling pathway to shut down tumor cell proliferation. Simultaneously, it targets and blocks Vascular Endothelial Growth Factor Receptors (VEGFR-2 and VEGFR-3) and Platelet-Derived Growth Factor Receptors (PDGFR-ß). This anti-angiogenic action deprives the tumor of its necessary blood supply, leading to cell death and tumor shrinkage.

  • Primary Clinical Indications:

    • Advanced Renal Cell Carcinoma (RCC): Prescribed for patients diagnosed with advanced or metastatic kidney cancer who have not responded to or have progressed on initial standard therapies.

    • Unresectable Hepatocellular Carcinoma (HCC): Deployed as a primary standard systemic treatment for patients with advanced liver cancer that cannot be surgically removed.

    • Differentiated Thyroid Carcinoma (DTC): Formulated for progressive, locally advanced, or metastatic thyroid cancer that has become refractory to radioactive iodine (RAI) treatment.

  • Administration Protocol: The standard therapeutic dosage typically consists of 400mg (two 200mg tablets) taken twice daily. The tablets must be swallowed whole with a glass of water, either 1 hour before a meal or 2 hours following a meal (on an empty stomach).

📦 Logistics & Sourcing Capabilities

  • Compliant Supply Lines: Sourced directly from modern manufacturing lines running under strict Good Manufacturing Practice (GMP) standards to guarantee clinical purity and batch uniformity.

  • Streamlined International Export: Advanced global shipping protocols configured to navigate complex customs clearances, cold-chain compliance when necessary, and importation regulatory frameworks within the USA, UK, Australia, and South Africa.

  • Institutional Sourcing Power: Fully prepared to manage large-scale wholesale contracts, health-system procurement orders, and public/private hospital supply tenders.

  • B2B Documentation Suite: Every single batch export is supported by certified documentation profiles including verified Certificates of Analysis (COA), customs clearances, and trace documentation.

PRESCRIPTION MEDICINE IS: YES

⚠️Disclaimer

Soralieva 200mg Tablet is a highly potent prescription oncology medication. It must strictly be administered under the direct authority, prescription, and ongoing clinical evaluation of a registered medical oncologist. This informational outline is designed exclusively for international B2B trade, professional procurement officers, and global commercial pharmaceutical networks; it does not replace or

 constitute professional medical advice.


📞 Contact Ernest Oncology — Global Medicine Exporter

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]


🌐 Websites:

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

🔗 WhatsApp Direct Link:https://wa.me/919359902383


 2026-05-20T07:02:29

Keywords